Molecular Profiling of ADAM12 in Human Bladder Cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Cancer Research

• Publication date

  2006-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-1066PMID 17189408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2006

  2006cited by this paper
• ADAM12 Is a Four-leafed Clover

  2006influential reference
• A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

  2005cited by this paper
• A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.

  2005cited by this paper
• Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells.

  2005cited by this paper
• A role for ADAM12 in breast tumor progression and stromal cell apoptosis.

  2005cited by this paper
• The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.

  2005cited by this paper
• Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer.

  2005cited by this paper
• Critical function for ADAM9 in mouse prostate cancer.

  2005cited by this paper
• Hierarchy of ADAM12 binding to integrins in tumor cells.

  2005cited by this paper
• Increased expression of ADAM family members in human breast cancer and breast cancer cell lines

  2004cited by this paper
• Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases

  2004cited by this paper
• Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?)

  2004cited by this paper
• Regulation of ADAM12 Cell-surface Expression by Protein Kinase C ϵ*

  2004cited by this paper
• ADAM 12 Cleaves Extracellular Matrix Proteins and Correlates with Cancer Status and Stage*

  2004influential reference
• Tumorigenesis and Neoplastic Progression ADAM12 Is Selectively Overexpressed in Human Glioblastomas and Is Associated with Glioblastoma Cell Proliferation and Shedding of Heparin-Binding Epidermal Growth Factor

  2004cited by this paper
• Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.

  2003cited by this paper
• Identifying distinct classes of bladder carcinoma using microarrays

  2003cited by this paper
• Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

  2003influential reference
• The ADAMs family of metalloproteases: multidomain proteins with multiple functions.

  2003cited by this paper
• Uroplakin gene expression in normal human tissues and locally advanced bladder cancer

  2003cited by this paper
• ADAM12 in human liver cancers: TGF‐β‐regulated expression in stellate cells is associated with matrix remodeling

  2003influential reference
• A secreted form of human ADAM9 has an α-secretase activity for APP☆

  2002cited by this paper
• The expression of ADAM12 (meltrin α) in human giant cell tumours of bone

  2002cited by this paper
• A secreted form of human ADAM9 has an alpha-secretase activity for APP.

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone.

  2002cited by this paper
• ADAM 12 protease induces adipogenesis in transgenic mice.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The Cysteine-Rich Domain of Human Adam 12 Supports Cell Adhesion through Syndecans and Triggers Signaling Events That Lead to β1 Integrin–Dependent Cell Spreading

  2000cited by this paper
• ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.

  2000cited by this paper
• URINE CYTOLOGY: Is it Still the Gold Standard for Screening?

  2000cited by this paper
• Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

  2000cited by this paper
• MDC-L, a Novel Metalloprotease Disintegrin Cysteine-rich Protein Family Member Expressed by Human Lymphocytes*

  1999cited by this paper
• Survival of patients with carcinoma in situ of the urinary bladder

  1999cited by this paper
• Primary Uroepithelial Cultures

  1999cited by this paper
• Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion.

  1999influential reference
• A Novel, Secreted Form of Human ADAM 12 (Meltrin α) Provokes Myogenesis in Vivo *

  1998cited by this paper
• The treated natural history of high risk superficial bladder cancer: 15-year outcome.

  1997cited by this paper
• Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing.

  1995cited by this paper
• The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma

  1987cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• ADAM12-programmed ECM-CAF remodeling activates PI3K-AKT and enforces an immune-excluded microenvironment to drive bladder cancer progression and therapy resistance.

  2026cites this paper
• ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy.

  2025cites this paper
• Contributions of ADAM12 via HB-EGF/EGFR signaling cascades to EMT and cancer progression in pancreas

  2025cites this paper
• ADAM12-Generated Basigin Ectodomain Binds β1 Integrin and Enhances the Expression of Cancer-Related Extracellular Matrix Proteins

  2024cites this paper
• Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway.

  2023cites this paper
• Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis

  2023cites this paper
• ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy

  2023cites this paper
• ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway

  2023cites this paper
• Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated with surgical resection and perioperative chemotherapy.

  2022cites this paper
• Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

  2022cites this paper
• ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer

  2022cites this paper
• Expression of ADAM12 in Gastric Cancer and its Relation to Tumor Cell Behavior and Prognosis

  2022cites this paper
• Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use

  2022cites this paper
• Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique

  2021influential citation
• Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real‐time PCR

  2021cites this paper
• A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer

  2021cites this paper
• The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells

  2020cites this paper
• OTT_A_242854 4305..4318

  2020cites this paper
• OTT_A_246710 4157..4168

  2020cites this paper
• Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database

  2020cites this paper
• SP1-Mediated Upregulation of lncRNA LINC01614 Functions a ceRNA for miR-383 to Facilitate Glioma Progression Through Regulation of ADAM12

  2020cites this paper
• Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis

  2019cites this paper
• Differential roles of protease isoforms in the tumor microenvironment

  2019cites this paper
• Identification of ADAM12 as a Novel Basigin Sheddase

  2019cites this paper
• An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.

  2018cites this paper
• A Disintegrin and Metalloproteases (ADAMs) in Cardiovascular, Metabolic and Inflammatory Diseases: Aspects for Theranostic Approaches

  2018cites this paper
• ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

  2018cites this paper
• Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a

  2018cites this paper
• Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12.

  2018cites this paper
• Association between ADAM12 Single-Nucleotide Polymorphisms and Knee Osteoarthritis: A Meta-Analysis

  2017cites this paper
• ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling

  2017cites this paper
• ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions

  2017cites this paper
• Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren’s disease

  2016cites this paper
• Quantitative proteomics identifies myoferlin as a novel regulator of A Disintegrin and Metalloproteinase 12 in HeLa cells.

  2016cites this paper
• Tumor Microenvironment Gene Signature as a Prognostic Classifier and Therapeutic Target

  2016cites this paper
• Metalloproteinases ADAM12 and MMP‐14 are associated with cavernous sinus invasion in pituitary adenomas

  2016cites this paper
• The role of CDCP1 (CUB domain-containing protein 1) and ADAM12 (a disintegrin and metalloproteinase 12) in ovarian cancer.

  2015cites this paper
• Introduction The role of CDCP 1 ( CUB domain-containing protein 1 ) and ADAM 12 ( a disintegrin and metalloproteinase 12 ) in ovarian cancer

  2015cites this paper
• ADAM 12 expression predicts clinical outcome in estrogen receptor-positive breast cancer

  2015cites this paper
• ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

  2015cites this paper
• ResearchADAM 10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases

  2015cites this paper
• The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition

  2015cites this paper
• A novel approach for feature selection based on MapReduce for biomarker discovery

  2015cites this paper
• Urinary ADAM12 and MMP-9/NGAL Complex Detect the Presence of Gastric Cancer

  2015cites this paper
• Effects of nitric oxide synthase deficiency on a disintegrin and metalloproteinase domain-containing protein 12 expression in mouse brain samples.

  2015cites this paper
• ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.

  2015influential citation
• Rôle de ADAM12 dans la Transition Epithélio-Mésenchymateuse

  2015influential citation
• Herstellung von Antikörpern gegen ADAM12 mittels Chicken Antibody Phage Display

  2015cites this paper
• Vitamin D, ADAM-12 and Carotid Artery Disease

  2015cites this paper
• Biomarker Discovery Based on Large-Scale Feature Selection and MapReduce

  2015cites this paper
• Erbb2 up‐regulation of ADAM12 expression accelerates skin cancer progression

  2015cites this paper
• AWARD NUMBER: W81XWH-14-1-0107 TITLE: Tumor Microenvironment Gene Signature as a Prognostic Classifier and Therapeutic Target PRINCIPAL INVESTIGATOR:

  2015cites this paper
• A substrate-optimized electrophoretic mobility shift assay for ADAM12.

  2014cites this paper
• A Disintegrin and Metalloproteinase-12 as a New Target for Cancer Treatment

  2014cites this paper
• Thomsen-Friedenreich antigens in bladder cancer: evaluation of their prognostic value

  2014cites this paper
• EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study

  2014cites this paper
• HOMOLOGY MODELING FOR HUMAN ADAM12 USING PRIME, I-TASSER AND EASYMODELLER

  2014cites this paper
• Matrix Metalloproteinase-9 ( MMP 9 ) — AMediating Enzyme in Cardiovascular Disease , Cancer , and Neuropsychiatric Disorders

  2014cites this paper
• Multiple isoforms of ADAM12 in breast cancer: differential regulation of expression and unique roles in cancer progression

  2014cites this paper
• Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation

  2014cites this paper
• Extravillous Trophoblast-Associated ADAM12 Exerts Pro-Invasive Properties, Including Induction of Integrin Beta 1-Mediated Cellular Spreading1

  2014cites this paper
• A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis.

  2013cites this paper
• Molecular Profiling of ADAM12 and ADAM17 Genes in Human Malignant Melanoma

  2013cites this paper
• Urinary biomarkers of bladder cancer: an update and future perspectives.

  2013cites this paper
• Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia

  2013cites this paper
• Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants

  2013cites this paper
• ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth

  2013cites this paper
• ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.

  2013cites this paper
• A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications.

  2013cites this paper
• Chapter 252 – ADAM12

  2013cites this paper
• Epigenetic regulation by Z-DNA silencer function controls cancer-associated ADAM-12 expression in breast cancer: cross-talk between MeCP2 and NF1 transcription factor family.

  2013cites this paper
• Risk of bone metastatization in breast cancer : role of matrix metalloproteinases and ADAMs tissue expression

  2013cites this paper
• Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.

  2012cites this paper
• Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2′-Deoxycytidine

  2012cites this paper
• Functional Analysis of a Breast Cancer-Associated Mutation in the Intracellular Domain of the Metalloprotease ADAM12

  2012cites this paper
• ADAM12 induces estrogen-independence in breast cancer cells

  2012cites this paper
• Metalloprotease (ADAM12-S) as a Predictor of Preeclampsia: Correlation with Severity, Maternal Complications, Fetal Outcome, and Doppler Parameters

  2012cites this paper
• Bladder Cancer Biology

  2012cites this paper
• ADAMs in Cancer

  2012cites this paper
• The role of Twist1 in promoting tumor invasion and metastasis by regulation of invadopodia formation

  2012cites this paper
• Une désintégrine et métalloprotéase 12 (ADAM12)

  2012cites this paper
• Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival

  2012cites this paper
• mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma

  2012cites this paper
• Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.

  2012cites this paper
• Cell‐surface Metalloprotease ADAM12 is Internalized by a Clathrin‐ and Grb2‐dependent Mechanism

  2012cites this paper
• PKCα and PKCδ Regulate ADAM17-Mediated Ectodomain Shedding of Heparin Binding-EGF through Separate Pathways

  2011cites this paper
• Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity.

  2011cites this paper
• Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12

  2011cites this paper
• Potential of fluorescent metalloproteinase substrates for cancer detection.

  2011cites this paper
• ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor Progression

  2011cites this paper
• ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth

  2011cites this paper
• ADAM12 (ADAM metallopeptidase domain 12 (meltrin alpha))

  2011cites this paper
• Aberrant Expression of Disintegrin-Metalloprotease Proteins in the Formation and Progression of Uterine Cervical Cancer

  2011cites this paper
• Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure.

  2011cites this paper
• The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

  2011cites this paper
• Complex patterns of ADAM12 mRNA and protein splice variants in the human placenta.

  2011cites this paper
• Cell cholesterol modulates metalloproteinase‐dependent shedding of low‐density lipoprotein receptor‐related protein‐1 (LRP‐1) and clearance function

  2011cites this paper
• Heterogeneity of metalloproteinase expression in colorectal cancer - relation of molecular findings to basic morphology.

  2011cites this paper
• ADAM12 and ADAM17 Gene Expression in Laser-capture Microdissected and Non-microdissected Breast Tumors

  2011cites this paper
• Molecular dissection of abnormal wound healing processes resulting in keloid disease

  2010cites this paper